PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates
Open Access
- 27 June 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 66 (9) , 1976-1982
Abstract
Antimicrobial use is recognized as a risk factor for Clostridium difficile infection (CDI) and outbreaks. We studied the relationship between PCR ribotype, antimicrobial susceptibility and the genetic basis of resistance in response to exposure to antimicrobial agents. C. difficile isolates were cultured from 133 CDI patients for whom recent antimicrobial drug exposure had been recorded. Isolates were ribotyped by PCR and assessed for their susceptibility to the macrolide–lincosamide–streptogramin B (MLSB) group of compounds (erythromycin and clindamycin) and fluoroquinolone antimicrobials (ciprofloxacin, levofloxacin and moxifloxacin). Where relevant, the genetic basis of resistance was determined. Prevalent ribotypes (including 027, 001 and 106) exhibited significantly greater antimicrobial resistance compared with ribotypes 078 and 014, among others. Clindamycin-resistant ribotype 078 was detected for the first time. Ribotypes 027 and 001 were more likely to exhibit MLSB resistance, a feature that was associated with the erm(B) gene. Exposure to MLSB or fluoroquinolone antimicrobial compounds in the 8 weeks prior to the onset of infection was not associated with specific genetic markers of resistance. Single amino acid substitutions in the A and B subunits of DNA gyrase were noted and were ribotype specific and linked to resistance to moxifloxacin. Resistance to MLSB and fluoroquinolone antimicrobial compounds is common among prevalent ribotypes of C. difficile. The genetic basis for antimicrobial resistance appears to be ribotype specific and conserved in the absence of recent antimicrobial selection pressure.Keywords
This publication has 36 references indexed in Scilit:
- Clindamycin-Resistant Clone of Clostridium difficile PCR Ribotype 027, EuropeEmerging Infectious Diseases, 2008
- First cluster of clindamycin-resistant Clostridium difficile PCR ribotype 027 in SwitzerlandClinical Microbiology and Infection, 2008
- Resistance determinants in strains of Clostridium difficile from two geographically distinct populationsInternational Journal of Antimicrobial Agents, 2004
- Analysis of Macrolide-Lincosamide-Streptogramin B (MLS B ) Resistance Determinant in Strains of Clostridium difficileMicrobial Drug Resistance, 2002
- Mechanisms of Resistance to Macrolides and Lincosamides: Nature of the Resistance Elements and Their Clinical ImplicationsClinical Infectious Diseases, 2002
- Genomic analysis of the erythromycin resistance element Tn5398 from Clostridium difficile The GenBank accession number for the Tn5398 element and flanking sequence is AF109075.Microbiology, 2001
- Epidemics of Diarrhea Caused by a Clindamycin-Resistant Strain ofClostridium difficilein Four HospitalsNew England Journal of Medicine, 1999
- Erythromycin resistance by ribosome modificationAntimicrobial Agents and Chemotherapy, 1995
- Characterization of the genetic basis of antibiotic resistance in Clostridium difficleJournal of Antimicrobial Chemotherapy, 1994
- Bacterial resistance to macrolide, lincosamide, and streptogramin antibiotics by target modificationAntimicrobial Agents and Chemotherapy, 1991